Sigilon Therapeutics Inc. (SGTX)
NASDAQ: SGTX
· Real-Time Price · USD
22.47
-0.59 (-2.56%)
At close: Aug 10, 2023, 10:00 PM
Sigilon Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -7.51M | -7.38M | -6.68M | -8.67M | -14.35M | -13.86M | -17.75M | -20.16M | -20.44M | -18.97M |
Depreciation & Amortization | 310K | 315K | 315K | 316K | 317K | 316K | 302K | 306K | 263K | 247K |
Stock-Based Compensation | 1.56M | 1.35M | 1.21M | 1.34M | 1.73M | 1.62M | 954K | 1.5M | 1.99M | 1.7M |
Other Working Capital | 792K | -6.12M | -393K | -4.26M | -2.59M | -3.16M | -1.31M | -3.95M | -1.47M | -7.53M |
Other Non-Cash Items | 987K | 1.03M | 987K | 923K | 975K | 1.29M | 1.29M | 1.26M | 1.24M | 1.26M |
Deferred Income Tax | 205K | n/a | n/a | n/a | n/a | 15K | 3K | n/a | n/a | n/a |
Change in Working Capital | 289K | -6.72M | -3.04M | -3.9M | -3.46M | -8.87M | -2.19M | -5.28M | 964K | -6.92M |
Operating Cash Flow | -4.16M | -11.4M | -7.22M | -9.99M | -14.78M | -19.49M | -17.38M | -22.37M | -15.99M | -22.67M |
Capital Expenditures | -139K | -351K | -25K | -6K | -109K | -397K | -302K | -535K | -707K | -290K |
Cash Acquisitions | n/a | n/a | 0.48 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -6.89M | n/a | 42.52M | -1.48M | -18.22M | -22.82M | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 6.88M | 12.59M | 18M | 9.75M | 3M | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 48K | n/a | -42.47M | 8K | 169K | n/a | -16.23M | n/a | n/a | n/a |
Investing Cash Flow | -108K | 12.24M | 18.03M | 8.27M | -15.16M | -23.22M | -16.53M | -535K | -707K | -290K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -17.37M | -1.64M | -1.67M | 13K | n/a | 48K | 657K | n/a | n/a | -477K |
Financial Cash Flow | -17.37M | -1.64M | -1.67M | 13K | n/a | 48K | 657K | 888K | 486K | -477K |
Net Cash Flow | -21.63M | -806K | 9.14M | -1.71M | -29.94M | -42.66M | -33.25M | -22.01M | -16.21M | -23.44M |
Free Cash Flow | -4.29M | -11.75M | -7.24M | -9.99M | -14.89M | -19.89M | -17.68M | -22.9M | -16.69M | -22.96M |